Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04317404 · ClinicalTrials.gov registry record
Knee Steroid Injection and Blood Sugar Signatur
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 11
- Enrollment target
NCT04317404: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT04317404 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04317404 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
A prospective, observational study assessing the relationship between HbA1c level and the post-injection blood glucose signature. Participants will be non-diabetic, pre-diabetic, non-insulin dependent and insulin dependent type 2 diabetic patients who will be receiving a knee steroid injection. All of them will be consented a week prior to the injection, when the CGM sensor will be applied to the back of the upper arm. This will be removed a week after the injection. KOOS survey as well as VAS will be administered. Adverse events (e.g., change in medication or hospitalization) will be monitored throughout the study.
Primary Outcome
Blood glucose levels after injection of steroid to the knee
Interventions
- DRUG 40 mg Triamcinolone acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2022-11-30 |
What the finished NCT04317404 record still lists
NCT04317404 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 40 mg Triamcinolone acetonide is the first listed.
NCT04317404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04317404 about?
NCT04317404 is a clinical study titled "Knee Steroid Injection and Blood Sugar Signatur". A prospective, observational study assessing the relationship between HbA1c level and the post-injection blood glucose signature. Participants will be non-diabetic, pre-diabetic, non-insulin dependent and insulin dependent type 2 diabetic patients who will be receiving a knee steroid injection. All ...
What is the current status of trial NCT04317404?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2020-11-01. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04317404?
The interventions under investigation include: 40 mg Triamcinolone acetonide (DRUG).
Who is sponsoring clinical trial NCT04317404?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI